Deregulation of fatty acid synthase activity, chronic inflammation and oxidative stress [37] may also contribute possible pathogenic mechanism for increased risk of breast and endometrial cancers in type 2 diabetes. Here, FASN is linked to type 2 diabetes mellitus.